News Sentiment

SLDB sentiment intelligence

Solid Biosciences LLC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 44 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 10.42 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 35

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

-3.9% over one week, +45.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Solid Biosciences (SLDB) Proxy filing Summary

Market Reaction

Balanced read

67/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction -3.9% Price reacting lower
Trend fit Trend active 45.9% over four weeks
Fair value 71.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 17
Neutral 26
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 35
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
TradingView 7
GlobeNewswire 4
Quartr 3
simplywall.st 3
Sahm 2
Simply Wall Street 2
Stock Titan 2

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 13
Balance sheet 4
Regulatory and legal 2
Analyst action 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-44 of 44
Zacks Investment Research Direct company coverage

Should I buy Solid Biosciences (SLDB)

Tone
Positive 66/100
Event
Market update
Published
16 Jan 2026 08:00
Source
Zacks Investment Research